Gilead Sciences Inc
NASDAQ: GILD
$91.69
+$1.47 (+1.6%)
Closing Price on November 6, 2024
GILD Articles
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The January 31 short interest data have been compared with the previous report, and short interest in...
Published:
Last Updated:
It's another disappointing day for one of America's top biotech companies. But that may prove to be great news for Intercept Pharmaceuticals.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday included BHP, Cisco Systems, Crown Castle, Gilead Sciences, Goldcorp, Take-Two Interactive Software, Varonis Systems and Whiting...
Published:
Last Updated:
Gilead Sciences is living up to our theory that Big Biotech is now effectively the same as Big Pharma.
Published:
Last Updated:
24/7 Wall St. has reviewed Disney, General Motors, Twitter and some of the other key stocks reporting earnings this coming week.
Published:
Last Updated:
There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower drug prices. Patients want the best of the best options for devices,...
Published:
Last Updated:
The January 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
The December 14 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Published:
Last Updated:
Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Published:
Last Updated:
Gilead shares made a slight gain early on Monday after the firm announced that there would be a big change at the top, in terms of its senior management. Not to mention, this executive is coming from...
Published:
Last Updated:
The November 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Published:
Last Updated:
The October 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
Gilead shares retreated on Friday after it reported mixed third-quarter financial results late on Thursday.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday included GoldCorp, Gilead, GrubHub, Hilton Worldwide, KKR, Raymond James and Western Digital.
Published:
Last Updated: